NCT03755401 Post-Traumatic Stress Disorder Focused Psychodynamic Psychotherapy
| NCT ID | NCT03755401 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Montefiore Medical Center |
| Condition | PTSD |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2018-11-02 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 75 participants in total. It began in 2018-11-02 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a randomized controlled trial of Trauma-Focused Psychodynamic Psychotherapy (TFPP) in comparison with TAU (at the VA) in a 2:1 ratio in 75 Veterans with PTSD who have not responded to standard treatment at the VA.
Eligibility Criteria
Inclusion Criteria: * Reporting moderate PTSD, as defined by a CAPS score of \>40 * Have at least one of the following history with CPT and/or PE: * offered and declined * dropped out of treatment * been determined unsuitable by their treatment team * received treatment but continue to experience symptoms meeting entrance criteria. * Require stabilization on psychiatric medication for 2 month period prior to entry into study to avoid confounding treatments Exclusion Criteria: * Presence of SCID-5 assessed psychotic disorder, bipolar disorder, or substance use that would interfere with trial demands * Severe suicidality that would require immediate crisis management * Organic mental syndromes, delirium, or unstable medical conditions that would interfere with trial demands * Inability to meet trial demands.
Contact & Investigator
Barbara Milrod, MD
PRINCIPAL INVESTIGATOR
Weill Medical College of Cornell University
Frequently Asked Questions
Who can join the NCT03755401 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying PTSD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03755401 currently recruiting?
Yes, NCT03755401 is actively recruiting participants. Contact the research team at Emily.Villeneuve@va.gov for enrollment information.
Where is the NCT03755401 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT03755401 clinical trial?
NCT03755401 is sponsored by Montefiore Medical Center. The principal investigator is Barbara Milrod, MD at Weill Medical College of Cornell University. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.